Minfeng Shu

1.2k total citations
30 papers, 890 citations indexed

About

Minfeng Shu is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Minfeng Shu has authored 30 papers receiving a total of 890 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 12 papers in Cancer Research and 6 papers in Immunology. Recurrent topics in Minfeng Shu's work include RNA modifications and cancer (7 papers), Cancer-related molecular mechanisms research (6 papers) and Virus-based gene therapy research (4 papers). Minfeng Shu is often cited by papers focused on RNA modifications and cancer (7 papers), Cancer-related molecular mechanisms research (6 papers) and Virus-based gene therapy research (4 papers). Minfeng Shu collaborates with scholars based in China, United States and Ethiopia. Minfeng Shu's co-authors include Guangmei Yan, Wenbo Zhu, Bernard Roizman, Sihan Wu, Yuehan Zhou, Yanqiu Ou, Brunella Taddeo, Yuxi Zhou, Xiaoke Zheng and Yuan Lin and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Oncogene.

In The Last Decade

Minfeng Shu

30 papers receiving 880 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Minfeng Shu China 17 586 396 115 101 90 30 890
Yannan Qin China 18 653 1.1× 203 0.5× 86 0.7× 151 1.5× 77 0.9× 40 1.0k
Koji Muramatsu Japan 12 794 1.4× 463 1.2× 76 0.7× 75 0.7× 114 1.3× 38 1.1k
Jérôme Kucharczak France 12 634 1.1× 360 0.9× 43 0.4× 77 0.8× 188 2.1× 14 1.0k
Xiaoling Wang China 21 830 1.4× 362 0.9× 65 0.6× 40 0.4× 86 1.0× 58 1.1k
Xing‐sheng Shu China 16 657 1.1× 197 0.5× 82 0.7× 56 0.6× 107 1.2× 39 929
Guobin Song China 14 318 0.5× 172 0.4× 136 1.2× 76 0.8× 154 1.7× 26 710
Andrew D. Hollenbach United States 18 937 1.6× 190 0.5× 137 1.2× 109 1.1× 172 1.9× 30 1.2k
Yan‐Lai Tang China 16 404 0.7× 109 0.3× 64 0.6× 42 0.4× 136 1.5× 50 722

Countries citing papers authored by Minfeng Shu

Since Specialization
Citations

This map shows the geographic impact of Minfeng Shu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Minfeng Shu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Minfeng Shu more than expected).

Fields of papers citing papers by Minfeng Shu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Minfeng Shu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Minfeng Shu. The network helps show where Minfeng Shu may publish in the future.

Co-authorship network of co-authors of Minfeng Shu

This figure shows the co-authorship network connecting the top 25 collaborators of Minfeng Shu. A scholar is included among the top collaborators of Minfeng Shu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Minfeng Shu. Minfeng Shu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Yuling, Jiamei Zhang, Bowen Yin, et al.. (2024). HSV-1-induced N6-methyladenosine reprogramming via ICP0-mediated suppression of METTL14 potentiates oncolytic activity in glioma. Cell Reports. 43(10). 114756–114756. 8 indexed citations
2.
Fan, Zhuoyang, Guowei Yang, Rongkui Luo, et al.. (2024). Sublethal heat treatment enhances lactic acid uptake in macrophages via MCT1, leading to reduced paraspeckle formation and a subsequent decrease in macrophage pyroptosis. Frontiers in Immunology. 14. 1290185–1290185. 4 indexed citations
3.
Fan, Zhuoyang, Bowen Yin, Xiaochen Chen, et al.. (2024). Comprehensive analysis of paraspeckle-associated gene modules unveils prognostic signatures and immunological relevance in multi-cancers. Discover Oncology. 15(1). 345–345. 1 indexed citations
4.
Dai, Weiwei, Ruotong Tian, Yuling Chen, et al.. (2024). Overcoming therapeutic resistance in oncolytic herpes virotherapy by targeting IGF2BP3-induced NETosis in malignant glioma. Nature Communications. 15(1). 131–131. 34 indexed citations
5.
Chen, Yuling, et al.. (2023). Comprehensive Analysis of Ferroptosis Regulators with Regard to PD-L1 and Immune Infiltration in Low-Grade Glioma. International Journal of Molecular Sciences. 24(16). 12880–12880. 2 indexed citations
6.
Tian, Ruotong, Yimin Li, & Minfeng Shu. (2022). Circadian Regulation Patterns With Distinct Immune Landscapes in Gliomas Aid in the Development of a Risk Model to Predict Prognosis and Therapeutic Response. Frontiers in Immunology. 12. 797450–797450. 8 indexed citations
7.
Liu, Qian, Ruotong Tian, Panpan Yu, & Minfeng Shu. (2021). miR‐221/222 suppression induced by activation of the cAMP/PKA/CREB1 pathway is required for cAMP‐induced bidirectional differentiation of glioma cells. FEBS Letters. 595(22). 2829–2843. 3 indexed citations
8.
Tian, Ruotong, Yimin Li, Qian Liu, & Minfeng Shu. (2021). Identification and Validation of an Immune-Associated RNA-Binding Proteins Signature to Predict Clinical Outcomes and Therapeutic Responses in Glioma Patients. Cancers. 13(7). 1730–1730. 12 indexed citations
9.
Fan, Zhuoyang, Yang Gao, Wei Zhang, et al.. (2021). METTL3/IGF2BP1/CD47 contributes to the sublethal heat treatment induced mesenchymal transition in HCC. Biochemical and Biophysical Research Communications. 546. 169–177. 22 indexed citations
10.
Wang, Yuyan, Ling Ding, Qing Zhu, Minfeng Shu, & Qiliang Cai. (2018). Common Infections May Lead to Alzheimer’s Disease. Virologica Sinica. 33(5). 456–458. 5 indexed citations
11.
Zhou, Yuxi, Sihan Wu, Chaofeng Liang, et al.. (2015). Transcriptional upregulation of microtubule-associated protein 2 is involved in the protein kinase A-induced decrease in the invasiveness of glioma cells. Neuro-Oncology. 17(12). 1578–1588. 17 indexed citations
12.
Zheng, Xiaoke, Yanqiu Ou, Minfeng Shu, et al.. (2014). Cholera toxin, a typical protein kinase A activator, induces G1 phase growth arrest in human bladder transitional cell carcinoma cells via inhibiting the c-Raf/MEK/ERK signaling pathway. Molecular Medicine Reports. 9(5). 1773–1779. 11 indexed citations
13.
Ou, Yanqiu, Xiaoke Zheng, Yixing Gao, et al.. (2013). Activation of cyclic AMP/PKA pathway inhibits bladder cancer cell invasion by targeting MAP4-dependent microtubule dynamics. Urologic Oncology Seminars and Original Investigations. 32(1). 47.e21–47.e28. 40 indexed citations
14.
Shu, Minfeng, Yuehan Zhou, Wenbo Zhu, et al.. (2011). MicroRNA 335 Is Required for Differentiation of Malignant Glioma Cells Induced by Activation of cAMP/Protein Kinase A Pathway. Molecular Pharmacology. 81(3). 292–298. 44 indexed citations
15.
16.
Wu, Sihan, Yuan Lin, Danyan Xu, et al.. (2011). MiR-135a functions as a selective killer of malignant glioma. Oncogene. 31(34). 3866–3874. 80 indexed citations
17.
Lu, Huimin, Yan Li, Minfeng Shu, et al.. (2009). Hypoxia‐inducible factor‐1α blocks differentiation of malignant gliomas. FEBS Journal. 276(24). 7291–7304. 27 indexed citations
18.
Zhu, Wenbo, Yanqiu Ou, Yan Li, et al.. (2009). A Small-Molecule Triptolide Suppresses Angiogenesis and Invasion of Human Anaplastic Thyroid Carcinoma Cells via Down-Regulation of the Nuclear Factor-κB Pathway. Molecular Pharmacology. 75(4). 812–819. 72 indexed citations
19.
Zhu, Wenbo, Yan Li, Pengxin Qiu, et al.. (2009). Anti-angiogenic activity of triptolide in anaplastic thyroid carcinoma is mediated by targeting vascular endothelial and tumor cells. Vascular Pharmacology. 52(1-2). 46–54. 33 indexed citations
20.
Xie, Jun, Minfeng Li, Yijun Huang, et al.. (2009). Anesthetic pentobarbital inhibits proliferation and migration of malignant glioma cells. Cancer Letters. 282(1). 35–42. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yannan Qin Breakdown of academic impact, for papers by Koji Muramatsu Breakdown of academic impact, for papers by Jérôme Kucharczak Breakdown of academic impact, for papers by Xiaoling Wang Breakdown of academic impact, for papers by Xing‐sheng Shu Breakdown of academic impact, for papers by Guobin Song Breakdown of academic impact, for papers by Andrew D. Hollenbach Breakdown of academic impact, for papers by Yan‐Lai Tang
Rankless by CCL
2026